Published in Arch Intern Med on May 12, 2003
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ (2010) 7.93
Epidemiology of Alzheimer disease. Nat Rev Neurol (2011) 4.13
The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT). Clin Trials (2014) 3.50
The PROGRESS trial three years later: time for a balanced report of effectiveness. BMJ (2004) 3.13
Vascular risk factors and dementia: how to move forward? Neurology (2009) 2.97
Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci (2009) 2.86
Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study. Arch Intern Med (2009) 2.82
Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study. Neurology (2013) 2.61
The Secondary Prevention of Small Subcortical Strokes (SPS3) study. Int J Stroke (2011) 2.35
Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag (2008) 2.13
Cognitive function, dementia and type 2 diabetes mellitus in the elderly. Nat Rev Endocrinol (2011) 1.92
Building disease-specific drug-protein connectivity maps from molecular interaction networks and PubMed abstracts. PLoS Comput Biol (2009) 1.90
Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies. CMAJ (2012) 1.86
Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem Pharmacol (2014) 1.86
Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.78
Risk of dementia hospitalisation associated with cardiovascular risk factors in midlife and older age: the Atherosclerosis Risk in Communities (ARIC) study. J Neurol Neurosurg Psychiatry (2009) 1.74
The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy. Can J Cardiol (2006) 1.67
The relationship between blood pressure and cognitive function. Nat Rev Cardiol (2010) 1.66
Age-associated reductions in cerebral blood flow are independent from regional atrophy. Neuroimage (2010) 1.55
Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial. Lancet Neurol (2014) 1.51
Clinical features and racial/ethnic differences among the 3020 participants in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial. J Stroke Cerebrovasc Dis (2012) 1.47
Healthy eating and reduced risk of cognitive decline: A cohort from 40 countries. Neurology (2015) 1.46
Mild cognitive impairment and dementia: the importance of modifiable risk factors. Dtsch Arztebl Int (2011) 1.43
Vascular risk factors and cognitive impairment in chronic kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) study. Clin J Am Soc Nephrol (2010) 1.32
Brain atrophy and white matter hyperintensity change in older adults and relationship to blood pressure. Brain atrophy, WMH change and blood pressure. J Neurol (2007) 1.28
Role of vascular risk factors and vascular dysfunction in Alzheimer's disease. Mt Sinai J Med (2010) 1.28
Vascular risk factors: imaging and neuropathologic correlates. J Alzheimers Dis (2010) 1.22
Promoting successful cognitive aging: a comprehensive review. J Alzheimers Dis (2010) 1.19
Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study. J Neurol Neurosurg Psychiatry (2007) 1.17
Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia. CMAJ (2008) 1.13
Subcortical ischemic vascular dementia. Neurol Clin (2007) 1.11
Update on the pharmacological treatment of Alzheimer's disease. Curr Neuropharmacol (2010) 1.07
An association analysis of Alzheimer disease candidate genes detects an ancestral risk haplotype clade in ACE and putative multilocus association between ACE, A2M, and LRRTM3. Am J Med Genet B Neuropsychiatr Genet (2009) 1.05
Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic review. Vasc Health Risk Manag (2010) 1.04
Vascular cognitive impairment: disease mechanisms and therapeutic implications. Neurotherapeutics (2011) 0.97
Blood pressure and dementia - a comprehensive review. Ther Adv Neurol Disord (2009) 0.95
Midlife hypertensive status and cognitive function 20 years later: the Southall and Brent revisited study. J Am Geriatr Soc (2013) 0.93
Models and mechanisms of vascular dementia. Exp Neurol (2015) 0.92
Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging. Age (Dordr) (2011) 0.92
Promotion of the mind through exercise (PROMoTE): a proof-of-concept randomized controlled trial of aerobic exercise training in older adults with vascular cognitive impairment. BMC Neurol (2010) 0.92
Nutrition and prevention of Alzheimer's dementia. Front Aging Neurosci (2014) 0.92
Effects of centrally acting ACE inhibitors on the rate of cognitive decline in dementia. BMJ Open (2013) 0.91
Heart disease as a risk factor for dementia. Clin Epidemiol (2013) 0.89
The effects of ramipril in individuals at risk for Alzheimer's disease: results of a pilot clinical trial. J Alzheimers Dis (2012) 0.89
Hypertension and cognitive function. Clin Geriatr Med (2009) 0.88
Potential role for angiotensin-converting enzyme inhibitors in the treatment of glaucoma. Clin Ophthalmol (2007) 0.87
Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association. Hypertension (2016) 0.87
Cognitive health begins at conception: addressing dementia as a lifelong and preventable condition. BMC Med (2013) 0.86
Lessons from a mouse model characterizing features of vascular cognitive impairment with white matter changes. J Aging Res (2011) 0.86
The Cache County Study on Memory in Aging: factors affecting risk of Alzheimer's disease and its progression after onset. Int Rev Psychiatry (2013) 0.84
Renin angiotensin system gene polymorphisms modify angiotensin-converting enzyme inhibitors' effect on cognitive function: the health, aging and body composition study. J Am Geriatr Soc (2010) 0.84
[Alzheimer Disease]. Can Fam Physician (2007) 0.83
Association between antihypertensive medication use and non-cardiovascular outcomes in older men. J Gen Intern Med (2007) 0.83
I brazilian position paper on antihypertensive drug combination. Arq Bras Cardiol (2014) 0.83
The Association between Hypertension and Dementia in the Elderly. Int J Hypertens (2011) 0.83
Carotid intima-media thickness is associated with cognitive deficiency in hypertensive patients with elevated central systolic blood pressure. Cardiovasc Ultrasound (2012) 0.82
Diabetes and the brain: issues and unmet needs. Neurol Sci (2014) 0.82
The Japan Statin Treatment Against Recurrent Stroke (J-STARS): A Multicenter, Randomized, Open-label, Parallel-group Study. EBioMedicine (2015) 0.82
Hypertension and cognitive decline in rural elderly Chinese. J Am Geriatr Soc (2009) 0.82
Calcium Channel Blockers, Progression to Dementia, and Effects on Amyloid Beta Peptide Production. Oxid Med Cell Longev (2015) 0.81
Hypertension, cognitive decline, and dementia: an epidemiological perspective. Dialogues Clin Neurosci (2007) 0.81
Use of diuretics is associated with reduced risk of Alzheimer's disease: the Cache County Study. Neurobiol Aging (2014) 0.81
A call for comparative effectiveness research to learn whether routine clinical care decisions can protect from dementia and cognitive decline. Alzheimers Res Ther (2016) 0.81
The evidence for treating hypertension in older people with dementia: a systematic review. J Hum Hypertens (2013) 0.80
Baseline cognitive function, recurrent stroke, and risk of dementia in patients with stroke. Stroke (2013) 0.80
The association between the prevalence, treatment and control of hypertension and the risk of mild cognitive impairment in an elderly urban population in China. Hypertens Res (2016) 0.79
ACE polymorphism and use of ACE inhibitors: effects on memory performance. Age (Dordr) (2014) 0.79
Vascular disease and cognitive impairment. Expert Rev Neurother (2008) 0.79
Hypertension and cognitive dysfunction in elderly: blood pressure management for this global burden. BMC Cardiovasc Disord (2016) 0.78
Cardiovascular prevention of cognitive decline. Cardiol Res Pract (2011) 0.78
Neuroimaging in dementia. Semin Neurol (2008) 0.78
The inclusion of cognition in vascular risk factor clinical practice guidelines. Clin Interv Aging (2009) 0.78
Cognitive impairment six months after ischaemic stroke: a profile from the ASPIRE-S study. BMC Neurol (2015) 0.78
Cost-effectiveness of antihypertensive treatment in patients 80 years of age or older in Switzerland: an analysis of the HYVET study from a Swiss perspective. J Hum Hypertens (2009) 0.78
Antihypertensives for combating dementia? A perspective on candidate molecular mechanisms and population-based prevention. Transl Psychiatry (2012) 0.77
Diuretic use is associated with better learning and memory in older adults in the Ginkgo Evaluation of Memory Study. Alzheimers Dement (2012) 0.77
Prevention of dementia: Role of vascular risk factors and cerebral emboli. Indian J Psychiatry (2009) 0.76
Perindopril: the evidence of its therapeutic impact in hypertension. Core Evid (2007) 0.76
Cognitive state following stroke: the predominant role of preexisting white matter lesions. PLoS One (2014) 0.76
Drug repositioning approaches for the discovery of new therapeutics for Alzheimer's disease. Neurotherapeutics (2015) 0.76
Vascular cognitive change: perspective from neurology. Alzheimers Dement (2007) 0.76
When two are worse than one: stroke and Alzheimer disease. Neurology (2006) 0.76
Telmisartan Modulates Glial Activation: In Vitro and In Vivo Studies. PLoS One (2016) 0.76
Effects of Lactobacillus plantarum TWK10-Fermented Soymilk on Deoxycorticosterone Acetate-Salt-Induced Hypertension and Associated Dementia in Rats. Nutrients (2016) 0.76
Blood pressure control to prevent decline in cognition after stroke. Vasc Health Risk Manag (2015) 0.76
Hypertension and dementia in the elderly: the leisure world cohort study. Int J Hypertens (2011) 0.75
Economic evaluation of aerobic exercise training in older adults with vascular cognitive impairment: PROMoTE trial. BMJ Open (2017) 0.75
New directions for drug discovery. Dialogues Clin Neurosci (2006) 0.75
ACEI and ARB did not Reduce the Incidence of Dementia in Patients with Atrial Fibrillation: A Nationwide Cohort Study. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2013) 0.75
Vascular cognitive impairment, a cardiovascular complication. World J Psychiatry (2016) 0.75
Memory is preserved in older adults taking AT1 receptor blockers. Alzheimers Res Ther (2017) 0.75
The Age-Dependent Relationship between Blood Pressure and Cognitive Impairment: A Cross-Sectional Study in a Rural Area of Xi'an, China. PLoS One (2016) 0.75
Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink. Br J Clin Pharmacol (2015) 0.75
Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-β and tau pathology. Alzheimers Res Ther (2016) 0.75
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med (2008) 38.76
Treatment of hypertension in patients 80 years of age or older. N Engl J Med (2008) 21.04
Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med (2008) 19.76
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet (2010) 18.36
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet (2001) 17.97
Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med (2013) 14.78
Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med (2013) 11.10
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet (2011) 9.07
Severe hypoglycemia and risks of vascular events and death. N Engl J Med (2010) 8.54
Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ (2005) 6.83
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA (2012) 6.26
Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. Lancet (2010) 6.23
Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet (2014) 6.23
Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries. Lancet (2013) 6.19
Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int (2011) 6.01
Chronic diseases now a leading cause of death in rural India--mortality data from the Andhra Pradesh Rural Health Initiative. Int J Epidemiol (2006) 5.60
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47
Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol (2008) 5.40
Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet (2011) 5.33
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int (2011) 5.25
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet (2012) 5.10
Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. J Clin Epidemiol (2008) 5.05
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet (2012) 4.75
Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials. Lancet (2009) 4.73
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial. Lancet (2011) 4.67
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet (2012) 4.63
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet (2016) 4.49
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol (2009) 4.43
Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation (2008) 4.29
Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med (2007) 3.97
Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis. Ann Intern Med (2014) 3.81
Early supported discharge services for stroke patients: a meta-analysis of individual patients' data. Lancet (2005) 3.56
Imputations of missing values in practice: results from imputations of serum cholesterol in 28 cohort studies. Am J Epidemiol (2004) 3.52
Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch Intern Med (2005) 3.44
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. Kidney Int (2013) 3.42
Population Health Metrics Research Consortium gold standard verbal autopsy validation study: design, implementation, and development of analysis datasets. Popul Health Metr (2011) 3.21
The global burden of diabetes and its complications: an emerging pandemic. Eur J Cardiovasc Prev Rehabil (2010) 3.20
Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev (2007) 3.16
Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burden. J Hypertens (2006) 3.12
Risk prediction models: II. External validation, model updating, and impact assessment. Heart (2012) 3.05
Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation (2005) 2.97
Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich) (2013) 2.94
Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. J Hypertens (2014) 2.82
Body-mass index and cancer mortality in the Asia-Pacific Cohort Studies Collaboration: pooled analyses of 424,519 participants. Lancet Oncol (2010) 2.81
The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer (2009) 2.81
Role of mobile phones in motor vehicle crashes resulting in hospital attendance: a case-crossover study. BMJ (2005) 2.80
Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med (2009) 2.79
Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker. Heart (2012) 2.76
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med (2014) 2.64
Do we need to adjudicate major clinical events? Clin Trials (2008) 2.61
A systematic review of the impact of adherence on the effectiveness of e-therapies. J Med Internet Res (2011) 2.47
Blood pressure and the global burden of disease 2000. Part 1: estimates of blood pressure levels. J Hypertens (2006) 2.43
Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. Eur Heart J (2008) 2.41
Using verbal autopsy to measure causes of death: the comparative performance of existing methods. BMC Med (2014) 2.39
Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J Hypertens (2006) 2.37